These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 15680457)

  • 1. A common LRRK2 mutation in idiopathic Parkinson's disease.
    Gilks WP; Abou-Sleiman PM; Gandhi S; Jain S; Singleton A; Lees AJ; Shaw K; Bhatia KP; Bonifati V; Quinn NP; Lynch J; Healy DG; Holton JL; Revesz T; Wood NW
    Lancet; 2005 Jan 29-Feb 4; 365(9457):415-6. PubMed ID: 15680457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.
    Nichols WC; Pankratz N; Hernandez D; Paisán-Ruíz C; Jain S; Halter CA; Michaels VE; Reed T; Rudolph A; Shults CW; Singleton A; Foroud T;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):410-2. PubMed ID: 15680455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
    Fung HC; Chen CM; Hardy J; Hernandez D; Singleton A; Wu YR
    Mov Disord; 2006 Jun; 21(6):880-1. PubMed ID: 16511860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease.
    Di Fonzo A; Rohé CF; Ferreira J; Chien HF; Vacca L; Stocchi F; Guedes L; Fabrizio E; Manfredi M; Vanacore N; Goldwurm S; Breedveld G; Sampaio C; Meco G; Barbosa E; Oostra BA; Bonifati V;
    Lancet; 2005 Jan 29-Feb 4; 365(9457):412-5. PubMed ID: 15680456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study.
    Healy DG; Falchi M; O'Sullivan SS; Bonifati V; Durr A; Bressman S; Brice A; Aasly J; Zabetian CP; Goldwurm S; Ferreira JJ; Tolosa E; Kay DM; Klein C; Williams DR; Marras C; Lang AE; Wszolek ZK; Berciano J; Schapira AH; Lynch T; Bhatia KP; Gasser T; Lees AJ; Wood NW;
    Lancet Neurol; 2008 Jul; 7(7):583-90. PubMed ID: 18539534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
    Goldwurm S; Di Fonzo A; Simons EJ; Rohé CF; Zini M; Canesi M; Tesei S; Zecchinelli A; Antonini A; Mariani C; Meucci N; Sacilotto G; Sironi F; Salani G; Ferreira J; Chien HF; Fabrizio E; Vanacore N; Dalla Libera A; Stocchi F; Diroma C; Lamberti P; Sampaio C; Meco G; Barbosa E; Bertoli-Avella AM; Breedveld GJ; Oostra BA; Pezzoli G; Bonifati V
    J Med Genet; 2005 Nov; 42(11):e65. PubMed ID: 16272257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel P755L mutation in LRRK2 gene associated with Parkinson's disease.
    Wu T; Zeng Y; Ding X; Li X; Li W; Dong H; Chen S; Zhang X; Ma G; Yao J; Deng X
    Neuroreport; 2006 Dec; 17(18):1859-62. PubMed ID: 17179858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.
    Squillaro T; Cambi F; Ciacci G; Rossi S; Ulivelli M; Malandrini A; Mencarelli MA; Mari F; Renieri A; Ariani F
    J Hum Genet; 2007; 52(3):201-204. PubMed ID: 17235449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.
    Khan NL; Jain S; Lynch JM; Pavese N; Abou-Sleiman P; Holton JL; Healy DG; Gilks WP; Sweeney MG; Ganguly M; Gibbons V; Gandhi S; Vaughan J; Eunson LH; Katzenschlager R; Gayton J; Lennox G; Revesz T; Nicholl D; Bhatia KP; Quinn N; Brooks D; Lees AJ; Davis MB; Piccini P; Singleton AB; Wood NW
    Brain; 2005 Dec; 128(Pt 12):2786-96. PubMed ID: 16272164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.
    Gandhi PN; Chen SG; Wilson-Delfosse AL
    J Neurosci Res; 2009 May; 87(6):1283-95. PubMed ID: 19025767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LRRK2 in Parkinson's disease - drawing the curtain of penetrance: a commentary.
    Krüger R
    BMC Med; 2008 Nov; 6():33. PubMed ID: 18986509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 mutations in a clinic-based cohort of Parkinson's disease.
    Scholz S; Mandel RJ; Fernandez HH; Foote KD; Rodriguez RL; Barton E; Munson S; Singleton A; Okun MS
    Eur J Neurol; 2006 Dec; 13(12):1298-301. PubMed ID: 17116211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
    Marongiu R; Ghezzi D; Ialongo T; Soleti F; Elia A; Cavone S; Albanese A; Altavista MC; Barone P; Brusa L; Cortelli P; Petrozzi L; Scaglione C; Stanzione P; Tinazzi M; Zeviani M; Dallapiccola B; Bentivoglio AR; Valente EM; Garavaglia B;
    Mov Disord; 2006 Aug; 21(8):1232-5. PubMed ID: 16622859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathologic features of families with LRRK2-associated Parkinson's disease.
    Whaley NR; Uitti RJ; Dickson DW; Farrer MJ; Wszolek ZK
    J Neural Transm Suppl; 2006; (70):221-9. PubMed ID: 17017533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel LRRK2 mutation in a mainland Chinese patient with familial Parkinson's disease.
    Wang L; Guo JF; Nie LL; Xu Q; Zuo X; Sun QY; Yan XX; Tang BS
    Neurosci Lett; 2010 Jan; 468(3):198-201. PubMed ID: 19879329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation.
    Lorenzo-Betancor O; Samaranch L; Ezquerra M; Tolosa E; Lorenzo E; Irigoyen J; Gaig C; Pastor MA; Soto-Ortolaza AI; Ross OA; Rodríguez-Oroz MC; Valldeoriola F; Martí MJ; Luquin MR; Perez-Tur J; Burguera JA; Obeso JA; Pastor P
    Mov Disord; 2012 Jan; 27(1):146-51. PubMed ID: 22038903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.